News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year20272026202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 Dr. Lucas Moreno, new president-elect of the group in neuroblastoma in Europe (SIOPEN) 08/02/2023 Vall d'Hebron will develop medicines for children with a 3D printer 31/01/2023 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 Vall d’Hebron has reached a record number of clinical trials despite the pandemic 19/05/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder 28/03/2021 Self-injurious behaviors are among the main reasons why children and adolescents consult in mental health emergency room 26/03/2021 A study where Vall d’Hebron participates analyses the risk genetic factors shared between ADHD and disruptive behaviour disorders 17/02/2021 A Vall d'Hebron study shows that more than half of pregnant women suffered from symptoms of depression or anxiety during lockdown 05/02/2021 Genetic predisposition favors cannabis use in people with ADHD 16/01/2019 Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 23/04/2018 Pagination « First First page ‹ Previous Previous page 1 2 3 4 5